RxDoctor Payments Data

Daniel Elsholz

Pediatric Endocrinology · Saginaw, MINPI 1902847122

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 116 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Medtronic at 26.7% of the total. 2025 is the largest year on record at $760, 3.0 times the $253 reported in 2019.

$3,010in general payments, 2019–2025

Across 116 payments — averaging $25.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$804
  • Insulet Corporation$474
  • Dexcom, Inc.$413
  • AstraZeneca$193
  • Novo Nordisk$174
  • Azurity Pharmaceuticals, Inc.$162
  • plus $791 from 19 others

What the payments were for

  • Food & beverage$3,010100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,010 in reported general payments places this provider in the 75th percentile of 27 pediatric endocrinology providers in Michigan.

See all pediatric endocrinology providers in Michigan

Other pediatric endocrinology in Saginaw

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →